Foundpac Group Bhd
KLSE:FPGROUP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Foundpac Group Bhd
KLSE:FPGROUP
|
MY |
|
Iqstel Inc
OTC:IQST
|
US |
|
SKF India Ltd
NSE:SKFINDIA
|
IN |
|
J
|
Johnson Pharmacare Ltd
BSE:532154
|
IN |
|
Glory Flame Holdings Ltd
HKEX:8059
|
HK |
|
S
|
Solteq Oyj
OMXH:SOLTEQ
|
FI |
|
AK Medical Holdings Ltd
HKEX:1789
|
CN |
Balance Sheet
Balance Sheet Decomposition
Foundpac Group Bhd
Foundpac Group Bhd
Balance Sheet
Foundpac Group Bhd
| Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
5
|
4
|
6
|
20
|
46
|
33
|
32
|
51
|
56
|
33
|
7
|
30
|
27
|
|
| Cash |
5
|
4
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
33
|
7
|
2
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
20
|
46
|
33
|
32
|
51
|
56
|
0
|
0
|
28
|
27
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
47
|
26
|
0
|
|
| Total Receivables |
6
|
7
|
6
|
8
|
8
|
10
|
12
|
15
|
10
|
18
|
15
|
12
|
10
|
|
| Accounts Receivables |
6
|
7
|
6
|
8
|
8
|
9
|
12
|
14
|
9
|
16
|
14
|
12
|
10
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
0
|
0
|
|
| Inventory |
2
|
2
|
3
|
3
|
3
|
3
|
3
|
4
|
5
|
13
|
10
|
8
|
4
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
2
|
6
|
0
|
0
|
1
|
4
|
5
|
0
|
|
| Total Current Assets |
14
|
14
|
16
|
32
|
57
|
48
|
53
|
70
|
71
|
82
|
83
|
48
|
41
|
|
| PP&E Net |
12
|
11
|
16
|
16
|
14
|
17
|
23
|
25
|
24
|
24
|
23
|
25
|
62
|
|
| PP&E Gross |
12
|
11
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
24
|
23
|
25
|
0
|
|
| Accumulated Depreciation |
4
|
4
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
27
|
30
|
32
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
13
|
13
|
13
|
15
|
17
|
16
|
13
|
9
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
34
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
4
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
13
|
13
|
13
|
15
|
17
|
16
|
13
|
9
|
|
| Total Assets |
26
N/A
|
25
-5%
|
33
+31%
|
47
+46%
|
72
+51%
|
77
+8%
|
89
+16%
|
108
+21%
|
111
+3%
|
125
+13%
|
123
-2%
|
121
-2%
|
146
+21%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
3
|
2
|
3
|
3
|
2
|
3
|
3
|
4
|
5
|
9
|
4
|
9
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
| Other Current Liabilities |
4
|
4
|
5
|
1
|
0
|
0
|
1
|
1
|
1
|
6
|
6
|
0
|
2
|
|
| Total Current Liabilities |
7
|
6
|
7
|
3
|
2
|
3
|
4
|
6
|
5
|
16
|
11
|
10
|
10
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
33
|
|
| Deferred Income Tax |
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
4
|
4
|
2
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
8
N/A
|
7
-14%
|
10
+37%
|
5
-46%
|
4
-16%
|
7
+49%
|
9
+40%
|
12
+30%
|
12
+2%
|
22
+82%
|
16
-27%
|
14
-12%
|
46
+225%
|
|
| Equity | ||||||||||||||
| Common Stock |
2
|
2
|
2
|
33
|
52
|
52
|
52
|
60
|
60
|
60
|
62
|
62
|
63
|
|
| Retained Earnings |
12
|
12
|
15
|
9
|
16
|
19
|
26
|
34
|
38
|
42
|
44
|
44
|
37
|
|
| Unrealized Security Profit/Loss |
3
|
3
|
6
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
|
| Total Equity |
18
N/A
|
18
-1%
|
23
+29%
|
42
+85%
|
68
+60%
|
71
+5%
|
80
+13%
|
96
+20%
|
99
+3%
|
103
+4%
|
106
+3%
|
106
0%
|
100
-6%
|
|
| Total Liabilities & Equity |
26
N/A
|
25
-5%
|
33
+31%
|
47
+46%
|
72
+51%
|
77
+8%
|
89
+16%
|
108
+21%
|
111
+3%
|
125
+13%
|
123
-2%
|
121
-2%
|
146
+21%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
3
|
3
|
3
|
462
|
518
|
518
|
519
|
542
|
541
|
540
|
544
|
545
|
545
|
|